| Name | Vista View Care Center |
|---|---|
| Location | 8451 Pearl St, Thornton, Colorado |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 25 |
| Occupancy Rate | 73.2% |
| Medicare ID (CCN) | 065383 |
| Legal Business Name | Vibra Hospital Of Denver Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1316989163 |
| Organization Name | 8451 PEARL STREET OPERATING COMPANY, LLC |
| Doing Business As | VISTA VIEW CARE CENTER |
| Address | 8451 Pearl St, Thornton, CO 80229 |
| Phone Number | 303-288-3000 |
News Archive
XBiotech announced today enrollment of the first patient into its Phase III trial of Xilonix. The Pivotal study is designed to improve health and survival of late stage colorectal cancer patients with associated cachexia.
Mattel, Inc. today announced it will fund four university research projects focused on the impact of play in children's early development through Mattel's Philanthropy Programs.
Osteoarthritis is a debilitating and painful condition affecting more than 2.2 million Australians at a cost to the health system of $2.1 billion annually. As Australia's population ages and obesity rates climb, this figure is expected to grow to more than 3 million by 2030.
Alcohol and other drug (AOD) treatment and recovery research typically focuses on outcomes such as 'days abstinent.' Yet the degree to which individuals may be functioning better physically, socially and psychologically, how happy they may be, and their levels of self-esteem may be equally important as measures of progress.
Acurian announced today that it has been granted EU privacy certification from TRUSTe, the leading Internet privacy and security assurance program. TRUSTe will provide Acurian with third-party privacy claims and dispute resolution services, which will allow Acurian to broaden its patient recruitment and retention services in Europe. Acurian will display the TRUSTe seal of assurance on its websites.
› Verified 7 days ago
| NPI Number | 1447431473 |
| Organization Name | SOLAVISTA HOLDINGS LLC |
| Address | 8451 Pearl St, Thornton, CO 80229 |
| Phone Number | 303-286-5193 |
News Archive
XBiotech announced today enrollment of the first patient into its Phase III trial of Xilonix. The Pivotal study is designed to improve health and survival of late stage colorectal cancer patients with associated cachexia.
Mattel, Inc. today announced it will fund four university research projects focused on the impact of play in children's early development through Mattel's Philanthropy Programs.
Osteoarthritis is a debilitating and painful condition affecting more than 2.2 million Australians at a cost to the health system of $2.1 billion annually. As Australia's population ages and obesity rates climb, this figure is expected to grow to more than 3 million by 2030.
Alcohol and other drug (AOD) treatment and recovery research typically focuses on outcomes such as 'days abstinent.' Yet the degree to which individuals may be functioning better physically, socially and psychologically, how happy they may be, and their levels of self-esteem may be equally important as measures of progress.
Acurian announced today that it has been granted EU privacy certification from TRUSTe, the leading Internet privacy and security assurance program. TRUSTe will provide Acurian with third-party privacy claims and dispute resolution services, which will allow Acurian to broaden its patient recruitment and retention services in Europe. Acurian will display the TRUSTe seal of assurance on its websites.
› Verified 7 days ago
| NPI Number | 1518407410 |
| Organization Name | VIBRA HOSPITAL OF DENVER LLC |
| Address | 8451 Pearl St, Thornton, CO 80229 |
| Phone Number | 303-286-5199 |
News Archive
XBiotech announced today enrollment of the first patient into its Phase III trial of Xilonix. The Pivotal study is designed to improve health and survival of late stage colorectal cancer patients with associated cachexia.
Mattel, Inc. today announced it will fund four university research projects focused on the impact of play in children's early development through Mattel's Philanthropy Programs.
Osteoarthritis is a debilitating and painful condition affecting more than 2.2 million Australians at a cost to the health system of $2.1 billion annually. As Australia's population ages and obesity rates climb, this figure is expected to grow to more than 3 million by 2030.
Alcohol and other drug (AOD) treatment and recovery research typically focuses on outcomes such as 'days abstinent.' Yet the degree to which individuals may be functioning better physically, socially and psychologically, how happy they may be, and their levels of self-esteem may be equally important as measures of progress.
Acurian announced today that it has been granted EU privacy certification from TRUSTe, the leading Internet privacy and security assurance program. TRUSTe will provide Acurian with third-party privacy claims and dispute resolution services, which will allow Acurian to broaden its patient recruitment and retention services in Europe. Acurian will display the TRUSTe seal of assurance on its websites.
› Verified 7 days ago
| NPI Number | 1902882178 |
| Organization Name | 8451 PEARL ST OPERATING COMPANY |
| Address | 8451 Pearl St, Thornton, CO 80229 |
| Phone Number | 303-288-3000 |
News Archive
XBiotech announced today enrollment of the first patient into its Phase III trial of Xilonix. The Pivotal study is designed to improve health and survival of late stage colorectal cancer patients with associated cachexia.
Mattel, Inc. today announced it will fund four university research projects focused on the impact of play in children's early development through Mattel's Philanthropy Programs.
Osteoarthritis is a debilitating and painful condition affecting more than 2.2 million Australians at a cost to the health system of $2.1 billion annually. As Australia's population ages and obesity rates climb, this figure is expected to grow to more than 3 million by 2030.
Alcohol and other drug (AOD) treatment and recovery research typically focuses on outcomes such as 'days abstinent.' Yet the degree to which individuals may be functioning better physically, socially and psychologically, how happy they may be, and their levels of self-esteem may be equally important as measures of progress.
Acurian announced today that it has been granted EU privacy certification from TRUSTe, the leading Internet privacy and security assurance program. TRUSTe will provide Acurian with third-party privacy claims and dispute resolution services, which will allow Acurian to broaden its patient recruitment and retention services in Europe. Acurian will display the TRUSTe seal of assurance on its websites.
› Verified 7 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
XBiotech announced today enrollment of the first patient into its Phase III trial of Xilonix. The Pivotal study is designed to improve health and survival of late stage colorectal cancer patients with associated cachexia.
Mattel, Inc. today announced it will fund four university research projects focused on the impact of play in children's early development through Mattel's Philanthropy Programs.
Osteoarthritis is a debilitating and painful condition affecting more than 2.2 million Australians at a cost to the health system of $2.1 billion annually. As Australia's population ages and obesity rates climb, this figure is expected to grow to more than 3 million by 2030.
Alcohol and other drug (AOD) treatment and recovery research typically focuses on outcomes such as 'days abstinent.' Yet the degree to which individuals may be functioning better physically, socially and psychologically, how happy they may be, and their levels of self-esteem may be equally important as measures of progress.
Acurian announced today that it has been granted EU privacy certification from TRUSTe, the leading Internet privacy and security assurance program. TRUSTe will provide Acurian with third-party privacy claims and dispute resolution services, which will allow Acurian to broaden its patient recruitment and retention services in Europe. Acurian will display the TRUSTe seal of assurance on its websites.
› Verified 7 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 3 |
| Total Amount of Fines in Dollars | $2925 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 3 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 20 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 1.64 | 5.51 |